July 2012 FDA Recall Drug by Actavis
D-1693-2012 - Subpotent; some patches may not contain fentanyl gel

This Class II drug recall was voluntarily initiated by Actavis on July 11, 2012 for the product Drug. The FDA reported the reason for recall as subpotent; some patches may not contain fentanyl gel. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1693-2012

Reason for Recall
Subpotent; some patches may not contain fentanyl gel
Initiated
07-11-2012
Reported
10-03-2012
Quantity
98,088 cartons (5 pouches per carton)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.

Batch or Lot Expiration Information

Lot# Lot number 455040A (carton) 455040 (pouch)